neutralizing antibody selected plasma cells binds group group influenza hemagglutinins
isolation broadly neutralizing antibodies influenza viruses long-sought goal therapeutic approaches vaccine design using single-cell culture method screening large numbers human plasma cells isolated neutralizing monoclonal antibody recognized hemagglutinin ha glycoprotein subtypes neutralized group group influenza viruses passive transfer antibody conferred protection mice ferrets complexes group h1 group h3 subtypes analyzed x-ray crystallography showed antibody bound conserved epitope f subdomain antibody may used passive protection inform vaccine design broad specificity neutralization potency
